Clinical pharmacokinetics of the calcium antagonists
Calcium antagonists (C.A.T.S.) represent a heterogeneous group of pharmacons, being its mechanism of action the inhibition of the flow of entrance of calcium through type L depending-voltage channels of the membranes of the excitable cells. They are very liposoluble molecules which are well absorbed...
Guardado en:
| Autores principales: | Sesin, Jorge, Tamargo, Juan |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Español |
| Publicado: |
Instituto de Investigaciones Medicas
1997
|
| Materias: | |
| Acceso en línea: | http://pa.bibdigital.ucc.edu.ar/3722/1/A_Tamargo_Sesin.pdf |
| Aporte de: |
Ejemplares similares
-
Efecto del cilazapril, un inhibidor de la enzima de conversion, sobre la hipertrofia cardiovascular del paciente hipertenso
por: Sesin, Jorge, et al.
Publicado: (1996) -
Uracil/tegafur plus oral calcium folinate in advanced breast cancer
por: Richardet, Eduardo Arnoldo, et al.
Publicado: (1999) -
Clinical and Serological Features in Latin American IgG4-Related Disease Patients Differ According to Sex, Ethnicity, and Clinical Phenotype
por: Martín-Nares, Eduardo, et al.
Publicado: (2022) -
Sublingual immunotherapy in pediatric patients: Beyond clinical efficacy
por: Baena Cagnani, Carlos E., et al.
Publicado: (2005) -
Current Opinion in Allergy and Clinical Immunology: Editorial introductions
por: Tarlo, Susan, et al.
Publicado: (2010)